Answers are grounded in this paper and cite their sources.
This large two-centre analysis confirms favourable outcomes after LT for HCC. Tumour size and number, pre-transplant AFP, and Milan criteria remain important recipient HCC-risk factors. A higher donor risk (i.e. donor age, DCD grafts, ischaemia time) was associated with poorer outcomes.
No takes yet. Share an insight, caveat, or question.
Wehrle et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: